All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-18335052
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 18335052 A360T
Pol
gag-pol
HIV Infections
G
L
View
2 18335052 A360V
Pol
gag-pol
HIV Infections
G
L
View
3 18335052 A371V
Pol
gag-pol
HIV Infections
G
L
View
4 18335052 A400T
Pol
gag-pol
HIV Infections
G
L
View
5 18335052 G359S
Pol
gag-pol
HIV Infections
G
L
View
6 18335052 I326V
Pol
gag-pol
HIV Infections
G
L
View
7 18335052 I506L
Pol
gag-pol
HIV Infections
G
L
View
8 18335052 K366R
Pol
gag-pol
HIV Infections
G
L
View
9 18335052 K390R
Pol
gag-pol
HIV Infections
G
L
View
10 18335052 K512R
Pol
gag-pol
HIV Infections
G
L
View
11 18335052 K527N
Pol
gag-pol
HIV Infections
G
L
View
12 18335052 K530R
Pol
gag-pol
HIV Infections
G
L
View
13 18335052 Q547K
Pol
gag-pol
HIV Infections
G
L
View
14 18335052 R358K
Pol
gag-pol
HIV Infections
G
L
View
15 18335052 T470N
Pol
gag-pol
HIV Infections
G
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.